Physician profile
Diane E Ross
NPI 1447323001
$9,606.51
in general payments reported to CMS, 2019-2025
49 companies · $1,350 in 2025
The $1,350 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $915 · 2020: $1,293 · 2021: $1,506 · 2022: $1,662 · 2023: $1,442 · 2024: $1,439 · 2025: $1,350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,198 · Education: $32.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,197.94 |
| Education | $32.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $1,366.77 | 2019-2025 | Briviact, Zilbrysq, Rystiggo |
| Acadia Pharmaceuticals INC | $975.60 | 2019-2025 | Nuplazid |
| Sk Life Science, INC. | $743.95 | 2020-2025 | |
| Abbvie INC. | $676.03 | 2020-2025 | Qulipta, Ubrelvy, Duopa |
| Teva Pharmaceuticals USA, INC. | $539.11 | 2019-2025 | Austedo Xr, Austedo |
| Pfizer INC. | $481.02 | 2023-2025 | |
| Eisai INC. | $467.08 | 2019-2025 | |
| Emd Serono, INC. | $375.71 | 2020-2025 | Mavenclad |
| Lilly USA, LLC | $370.19 | 2019-2024 | Emgality, Amyvid, Reyvow |
| Mdd US Operations, LLC | $336.94 | 2019-2025 | Apokyn, Xadago, Gocovri |
| Biogen, INC. | $282.47 | 2019-2025 | Vumerity, Tysabri, Avonex |
| Harmony Biosciences LLC | $265.74 | 2020-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $226.19 | 2019-2025 | |
| Amgen INC. | $205.88 | 2019-2022 | |
| Amneal Pharmaceuticals LLC | $181.35 | 2019-2025 | Ongentys, Rytary |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diane Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.